Scopus by Title (Ref)

1. A nationwide study on the consumption and expenditure of osteoporosis medications in Iran during the period from 2001 to 2021

- Mousavi A. , et al.

2. Out-of-pocket pharmaceutical expenditure and its determinants among Iranian households with elderly members: a double-hurdle model

- Faraji M. , et al.

3. Drivers of vulnerability to medicine smuggling and combat strategies: a qualitative study based on online news media analysis in Iran

- Fakhrzad N.H. , et al.

4. Spectroscopic Screening of Dexamethasone and Cyproheptadine Adulteration in Weight Gaining Products Marketed in Aden, Yemen

- Badulla W.F.S. , et al.

5. Investigating the Relationship Between the Market Orientation Approach of Pharmaceutical Companies and Their Innovative Performance: The Mediating Role of Dynamic Capabilities and Corporate Social Responsibility

- Shirmohammadi J. , et al.

6. The current situation of medicinal and aromatic plants' industry, research, education, and standardization in Iran. How can traditional persian medicine products be successfully adapted to the needs of the European market?

- Nadjafi F. , et al.

7. Opinion of Polish Patients with Epilepsy on Generic Medications

- Swakowska K. , et al.

8. Occurrence, transformation, bioaccumulation, risk and analysis of pharmaceutical and personal care products from wastewater: a review

- Anand U. , et al.

9. Factors Affecting the Product Life Cycle of Generic Medicines

- Mousavi A. , et al.

10. Implications of national tax policy on local pharmaceutical production in a southwestern state nigeria – qualitative research for the intersection of national pharmaceutical policy on health systems development

- Obembe T.A. , et al.

11. A Clustering Approach to Identify the Organizational Life Cycle

- Mousavi A. , et al.

12. Developing a System Dynamic Model for Product Life Cycle Management of Generic Pharmaceutical Products: Its Relation with Open Innovation

- Mousavi A. , et al.

13. Critical Analysis of Corruption in Iran’s Health Care System and Its Control Strategies

- Joulaei H. , et al.

14. Health Systems of Iran and Portugal: A Comparative Study

- Mosadeghrad A.M. , et al.

15. Evaluation of the government's support policies for the pharmaceutical industry in the midst of sanctions and the covid-19 pandemic

- Amin-Tahmasbi H. , et al.

16. Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study

- Delpasand M. , et al.

17. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis

- Olyaaeemanesh A. , et al.

18. The Impact of Inflation and Its Uncertainty on Pharmaceutical Prices: Evidence from Iran

- Movahed M.S. , et al.

19. Estimation of the income and price elasticity of pharmaceutical import demand in Iran

- Otobideh S.A. , et al.

20. PHARMACEUTICAL EXPENDITURE AND GROSS DOMESTIC PRODUCT: THE CASE OF NORTH CYPRUS

- Çağer A. , et al.

21. An assessment of trends in the Iranian pharmaceutical market following domestic production of selected medications (2007‒2017) and new considerations for health policymakers

- Zargaran M. , et al.

22. Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data

- Kamyari N. , et al.

23. Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran

- Shahmirzadi N.A. , et al.

24. Extraction of cyproheptadine as potent appetizing stimulant in herbal supplements by efficient carbon nitride nanosheets as dispersive solid phase extraction adsorbent

- Taghvimi A. , et al.

25. Short and long term impacts of COVID-19 on the pharmaceutical sector

- Ayati N. , et al.